Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
serena.colafrancesco@uniroma1.it
Serena Colafrancesco
Ricercatore
Struttura:
DIPARTIMENTO DI SCIENZE CLINICHE INTERNISTICHE, ANESTESIOLOGICHE E CARDIOVASCOLARI
E-mail:
serena.colafrancesco@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Erratum. management of adult-onset still's disease with interleukin-1 inhibitors. evidence- and consensus-based statements by a panel of Italian experts
ARTHRITIS RESEARCH & THERAPY
2020
Targeting the immune system for pulmonary iInflammation and cardiovascular complications in COVID-19 patients
FRONTIERS IN IMMUNOLOGY
2020
COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
AUTOIMMUNITY REVIEWS
2020
Comparison of early vs. delayed anakinra treatment in patients with adult onset still's disease and effect on clinical and laboratory outcomes
FRONTIERS IN MEDICINE
2020
Autophagy occurs in lymphocytes infiltrating sjögren’s syndrome minor salivary glands and correlates with histological severity of salivary gland lesions
ARTHRITIS RESEARCH & THERAPY
2020
Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies sjögren's syndrome with ectopic germinal centres and MALT lymphoma
ANNALS OF THE RHEUMATIC DISEASES
2020
Validation of thymic stromal lymphopoietin as a biomarker of primary sjogren's syndrome and related lymphoproliferation. results in independent cohorts
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2020
Significance of anti-La/SSB antibodies in primary sjogren's syndrome patients with combined positivity for anti-Ro/SSA and salivary gland biopsy
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2020
Long-Term Retention Rate of Anakinra in Adult Onset Still's Disease and Predictive Factors for Treatment Response
FRONTIERS IN PHARMACOLOGY
2019
STAT4, TRAF3IP2, IL10, and HCP5 Polymorphisms in Sjögren's Syndrome: Association with Disease Susceptibility and Clinical Aspects
JOURNAL OF IMMUNOLOGY RESEARCH
2019
Phosphatidylinositol 3-kinase delta pathway: A novel therapeutic target for Sjögren's syndrome
ANNALS OF THE RHEUMATIC DISEASES
2019
Management of adult-onset Still's disease with interleukin-1 inhibitors.evidence- and consensus-based statements by a panel of Italian experts
ARTHRITIS RESEARCH & THERAPY
2019
TNFAIP3 gene polymorphisms in three common autoimmune diseases: Systemic lupus erythematosus, rheumatoid arthritis, and primary sjogren syndrome - association with disease susceptibility and clinical phenotypes in Italian patients
JOURNAL OF IMMUNOLOGY RESEARCH
2019
Anti-aminoacyl-tRNA synthetase-related myositis and dermatomyositis: clues for differential diagnosis on muscle biopsy
VIRCHOWS ARCHIV
2018
Tertiary lymphoid structures: Autoimmunity goes local
FRONTIERS IN IMMUNOLOGY
2018
Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset still's disease: A multicentre retrospective observational study
FRONTIERS IN PHARMACOLOGY
2017
Cryoglobulinemia in Sjögren syndrome: A disease subset that links higher systemic disease activity, autoimmunity, and local B Cell proliferation in mucosa-associated lymphoid tissue
THE JOURNAL OF RHEUMATOLOGY
2017
A snapshot on the on-label and off-label use of the interleukin-1 inhibitors in Italy among rheumatologists and pediatric rheumatologists: A nationwide multi-center retrospective observational study
FRONTIERS IN PHARMACOLOGY
2016
Sjögren's syndrome: from pathogenesis to novel therapeutic targets
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2016
Acute longitudinal myelitis following Cryptococcus laurentii pneumonia in a patient with systemic lupus erythematosus.
LUPUS
2015
« prima
< precedente
1
2
3
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma